Brussels deregulated gene-edited crops on 17 June 2026, citing climate adaptation, food security, and EU competitiveness. NGT-1 crops under 20 genetic modifications now skip risk assessment and traceability. But while labeling rules were dropped, patent rights for Bayer, Syngenta, and Corteva stayed untouched. This piece breaks down the real governance failure behind the CRISPR crop vote.
Corporate Social Responsibility (CSR) is no longer a side note in business. It’s a critical driver of success. But how do you create CSR strategies that truly make an impact online? How do you ensure your efforts resonate, engage, and deliver measurable results? The answer lies in mastering the art of online CSR strategies that are bold, authentic, and actionable. You might be wondering: Isn’t CSR…
Every ESG framework measures board composition and audit independence. Almost none ask the question that determines whether governance actually works: who decides which harms are worth measuring? That is not abstract. It has a documented history. In CSR, we call it materiality assessment. The mechanism sounds technical. It is not. It is a values decision dressed in accounting language. And when…
Forty years after Chernobyl, physical chemist and EU climate policy expert Dr. Audrey-Flore Ngomsik identifies the same governance failure in AI: unpriced environmental liability, silenced technical experts, and boards approving decisions they cannot evaluate. Three ESG pillars. All sources linked. August 2, 2026 deadline.
We spent two years as an external consultant watching companies hire managers and directors. They paid us to improve their processes. What we saw was a masterclass in how bias disguises itself as professional judgment. Same credentials on paper. Wildly different outcomes in practice. Here’s what nobody wants to admit.
Titanium dioxide nanoparticles found illegally in Sephora, Nocibé, René Furterer cosmetics. AVICENN investigation confirms EU Regulation 2022/1176 violations three years post-ban. French Health Ministry escalates to ANSES. Reformulation costs €200K minimum per product line. What's your company's regulatory exposure?
Over the past decade, while we were all watching these conferences with varying degrees of scepticism, something shifted. COP decisions stopped being theoretical and started showing up as line items on P&L statements. Some companies figured out how to profit from this. Others are still treating sustainability as a PR department problem. This is the story of what actually happened when climate…
Climate change isn’t just melting ice caps—it’s raising women’s cancer risks. A new study links every 1°C rise in temperature to higher rates of breast, ovarian, uterine, and cervical cancers. As a CSR strategist, I argue this isn’t just a health issue—it’s a justice issue. Climate, gender, and health are colliding, and women are paying the price. It’s time to treat climate action as women’s…